CDA and breast cancer: Collectively, the findings of Ye et al., 2015 established that miR-484-modulated CDA promotes chemoresistance while inhibiting cell proliferation in breast cancer, highlighting the pathophysiological exchange that arises because of chemoresistance in this cancerous condition (167).